BEVERLY HILLS, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (OTCQX:TOMZ), a global company specializing in disinfection and decontamination utilizes its premier Binary Ionization Technology® (BIT™) platform through the manufacturing, licensing, servicing, and selling of its SteraMist® brand of products - a hydrogen peroxide-based mist and fog, announced today that TOMI through its Israelian partner CleanCor Technologies has received its registration from The Ministry of Health Medical Technology Information and Research Division in the State of Israel, as a Medical Device.
Registration from The Ministry of Health Medical Technology Information and Research Division in the State of Israel expands TOMI's rights to ship products to the region. TOMI has partnered with CleanCor Technologies - a leading service provider in Israel specializing and involved in restoration of fire, water and natural damage remediation for the past 11 years and one of the leading companies in the State of Israel in this field. The company fulfills commercial and residential damage rehabilitation and provides solutions primarily for working with insurance companies. CleanCor has always used advanced solutions and SteraMist fits perfectly into their portfolio of products. Our new TOMI CleanCor partnership opens the door to deploy SteraMist throughout the State of Israel, addressing routine and emergency needs through enhanced decontamination and sterilization. Together, TOMI and CleanCor are innovating for a safer world.
Yaki Agam, CleanCor owner and founder, states "In the complexity of the State of Israel TOMI technology will help to find quick and professional solutions for unique problems. CleanCor looks forward to our partnership with TOMI Environmental Solutions. SteraMist is the future of decontamination, and we are ready to bring SteraMist service to the State of Israel.”
Dr. Halden Shane, TOMI CEO, states “TOMI has already shipped its first order to CleanCor and knows that the partnership with CleanCor will continue to expand throughout Israel. TOMI SteraMist® iHP™ technology will make a difference in decontamination throughout the State of Israel.”
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (OTCQX:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a hydroxyl radical (•OH ion), referred to as ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.
TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America and The Restoration Industry Association.
For additional information, please visit http://www.tomimist.com/ or contact us at info@tomimist.com.
CleanCor Technologies
Phone: +972-4-9531779
Fax: +972-4-9531778
E-Mail: yakiyes@netvision.net.il
https://www.cleancor.co.il
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release
INVESTOR RELATIONS CONTACT
Harold Paul
hpaul@tomimist.com